Health In Tech, Inc.
HITNASDAQTechnology● Active
$1.01
+$0.02(+2.33%)
Market Cap$54380530
P/E Ratio—
52W High$4.02
52W Low$0.555
Health In Tech, Inc. (HIT) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
HIT · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 13, 2026EPS Actual
-$0.03
Est. -$0.03 · -12.5%
Revenue
$0.01B
Est. $0.01B · +18.1%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 13, 2026
After Market Close
▼ Miss EPS▲ Beat Revenue
HIT reports quarterly as a NASDAQ-listed Software - Application company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Jul 20, 2026 | -$0.03 | — | — | — | $0.01B | — |
| ▼ Q2 FY2026 | May 13, 2026 | -$0.03 | -$0.03 | -12.5% | $0.01B | $0.01B | +18.1% |
| ▲ Q1 FY2026 | Mar 25, 2026 | -$0.04 | -$0.03 | +25.0% | $0.01B | $0.01B | +3.4% |
| — Q4 FY2025 | Nov 10, 2025 | $0.01 | $0.01 | +0.0% | $0.01B | $0.01B | +16.7% |
| — Q3 FY2025 | Jul 21, 2025 | $0.01 | $0.01 | +0.0% | $0.01B | $0.01B | +24.3% |
| ▼ Q2 FY2025 | Apr 14, 2025 | $0.02 | $0.01 | -50.0% | $0.01B | — | — |
| — Q1 FY2025 | Mar 18, 2025 | — | $0.01 | — | $0.00B | — | — |
| — Q1 FY2025 | Mar 17, 2025 | — | -$0.01 | — | $0.01B | — | — |
Q3 FY2026
Jul 20, 2026
EPS Actual
—
EPS Est.
-$0.03
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 13, 2026Miss
EPS Actual
-$0.03
EPS Est.
-$0.03
EPS Surpr.
-12.5%
Revenue
$0.01B
Q1 FY2026
Mar 25, 2026Beat
EPS Actual
-$0.03
EPS Est.
-$0.04
EPS Surpr.
+25.0%
Revenue
$0.01B
Q4 FY2025
Nov 10, 2025
EPS Actual
$0.01
EPS Est.
$0.01
EPS Surpr.
+0.0%
Revenue
$0.01B
Q3 FY2025
Jul 21, 2025
EPS Actual
$0.01
EPS Est.
$0.01
EPS Surpr.
+0.0%
Revenue
$0.01B
Q2 FY2025
Apr 14, 2025Miss
EPS Actual
$0.01
EPS Est.
$0.02
EPS Surpr.
-50.0%
Revenue
$0.01B
Q1 FY2025
Mar 18, 2025
EPS Actual
$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q1 FY2025
Mar 17, 2025
EPS Actual
-$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.01B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.05 | $0.05 | $0.06 | 1 |
| Q3 FY2027 | $0.04 | $0.04 | $0.05 | 1 |
| Q2 FY2027 | $0.03 | $0.04 | $0.04 | 1 |
| Q1 FY2027 | $0.03 | $0.04 | $0.04 | 1 |
| Q4 FY2026 | $0.01 | $0.01 | $0.01 | 1 |
| Q3 FY2026 | $-0.01 | $-0.01 | $-0.01 | 2 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2026 | $0.0B | $0.0B | $0.0B | 2 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2026 | May 13, 2026 | -12.5% | $1.52 | $1.54 | +1.32% |
| ▲ Q1 FY2026 | Mar 25, 2026 | +25.0% | $1.82 | $1.81 | -0.55% |
| ▲ Q4 FY2025 | Nov 10, 2025 | +0.0% | $2.91 | $2.92 | +0.34% |
| ▲ Q3 FY2025 | Jul 21, 2025 | +0.0% | $1.16 | $1.35 | +16.38% |
| ▼ Q2 FY2025 | Apr 14, 2025 | -50.0% | $0.70 | $0.69 | -1.86% |
| — Q1 FY2025 | Mar 18, 2025 | — | $0.83 | $0.68 | -18.21% |
| — Q1 FY2025 | Mar 17, 2025 | — | $0.82 | $0.83 | +1.59% |
| — Q2 FY2024 | Jun 30, 2024 | — | No price data | $5.10 | — |
Q2 FY2026+1.32%
Report Date
May 13, 2026
EPS Beat/Miss
-12.5%
Price Before
$1.52
Price After
$1.54
Q1 FY2026-0.55%
Report Date
Mar 25, 2026
EPS Beat/Miss
+25.0%
Price Before
$1.82
Price After
$1.81
Q4 FY2025+0.34%
Report Date
Nov 10, 2025
EPS Beat/Miss
+0.0%
Price Before
$2.91
Price After
$2.92
Q3 FY2025+16.38%
Report Date
Jul 21, 2025
EPS Beat/Miss
+0.0%
Price Before
$1.16
Price After
$1.35
Q2 FY2025-1.86%
Report Date
Apr 14, 2025
EPS Beat/Miss
-50.0%
Price Before
$0.70
Price After
$0.69
Q1 FY2025-18.21%
Report Date
Mar 18, 2025
EPS Beat/Miss
—
Price Before
$0.83
Price After
$0.68
Q1 FY2025+1.59%
Report Date
Mar 17, 2025
EPS Beat/Miss
—
Price Before
$0.82
Price After
$0.83
Q2 FY2024—
Report Date
Jun 30, 2024
EPS Beat/Miss
—
Price Before
—
Price After
$5.10
Avg Beat Reaction+5.39%
Avg Miss Reaction-0.27%
Beat Rate3 / 8 quarters
Largest Move-18.21% (Q1 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: HIT ends December
Health In Tech, Inc. (HIT) most recently reported earnings on May 13, 2026 for Q2 FY2026, posting EPS of $-0.03 — missing the analyst consensus of $-0.03 by -12.5%. The next HIT earnings date is expected around September 1, 2026.
Each quarter, investors track HIT earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. HIT revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
HIT's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
HIT earnings · 5 questionsHealth In Tech, Inc.'s next earnings report is expected around September 1, 2026. HIT typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; HIT historically reports after market close (AMC).
HIT earnings datewhen is HIT earningsHIT next earnings datewhen does HIT report earningsHIT earnings calendar
▸ Source: FMP · Health In Tech, Inc. SEC filings · US GAAP · Health In Tech, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026